Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of c-Kit Is Not Required for Reversal of Hyperglycemia by Imatinib in NOD Mice
Janet Lau, Qiang Zhou, Susan Sutton, et al.
PLoS ONE (2014) Vol. 9, Iss. 1, pp. e84900-e84900
Open Access | Times Cited: 10

Showing 10 citing articles:

Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?
Athanasios Fountas, Leonidas Nikolaos Diamantopoulos, Agathocles Tsatsoulis
Trends in Endocrinology and Metabolism (2015) Vol. 26, Iss. 11, pp. 643-656
Closed Access | Times Cited: 88
A PPARγ transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion
Yuwei Jiang, Daniel C. Berry, A-Young Jo, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 45
RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice
Brittany M. Duggan, Joseph F. Cavallari, Kevin P. Foley, et al.
Endocrinology (2020) Vol. 161, Iss. 8
Open Access | Times Cited: 19
Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor
Miguel Ángel Gómez-Sámano, Jorge Baquerizo‐Burgos, Marı́a Florencia Coronel, et al.
BMC Endocrine Disorders (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 20
Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS)
Jiang Du, Si Wang, Rui Wang, et al.
Pathology & Oncology Research (2019) Vol. 26, Iss. 1, pp. 91-100
Closed Access | Times Cited: 19
Tyrosine Kinase Targeting
Mohammad Althubiti
Saudi Journal of Medicine and Medical Sciences (2022) Vol. 10, Iss. 3, pp. 183-191
Open Access | Times Cited: 7
Kinase inhibitors for cancer alter metabolism, blood glucose, and insulin
Brittany M. Duggan, Daniel M. Marko, Raveen Muzaffar, et al.
Journal of Endocrinology (2022)
Open Access | Times Cited: 7
Imatinib prevents beta cell deathin vitrobut does not improve islet transplantation outcome
Aileen King, Lisa A. Griffiths, Shanta J. Persaud, et al.
Upsala Journal of Medical Sciences (2016) Vol. 121, Iss. 2, pp. 140-145
Open Access | Times Cited: 6
Are off-target effects of imatinib the key to improving beta-cell function in diabetes?
Nils Welsh
Upsala Journal of Medical Sciences (2022) Vol. 127
Open Access | Times Cited: 1
RIPK2 dictates insulin responses to tyrosine kinase inhibitors in obese mice
Brittany M. Duggan, Joseph F. Cavallari, Kevin P. Foley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Page 1

Scroll to top